Protecting patents by Native Americans
werner22brigitte; pixabay.com; CC0
Allergan gave their patents regarding a dry-eye drug to an American native tribe and payed them several million dollars as license fee. An already running attack on this patent based on IPR was rejected by lawyers of Allergan and the tribe, calling on “sovereign immunity”. In this particular case this was rejected by a federal judge due to obviousness of the patent content.
But this is only one of many examples of this kind of transaction. Not only Allergan but also major tech companies are trying to circumvent IPR by this mode of action. This also spread word in American politics and a United States Senator started fighting against this, in her eyes, sham.
Further reading is provided in the link section on the right at arstechnica.
Most read news
Organizations
Related link
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.